Researcher in medicinal chemistry, radiopharmaceuticals, and chemical biology, with a particular interest in the development of theranostic agents for cancer imaging and therapy. My work focuses on the design, synthesis, bioconjugation, and radiolabeling of biomolecules such as peptides and monoclonal antibodies targeting cancer-related biomarkers, including PD-L1. I am also interested in bioorthogonal chemistry, molecular imaging, and translational approaches in nuclear medicine and oncology.
Researcher in medicinal chemistry, radiopharmaceuticals, and chemical biology, with a particular interest in the development of theranostic agents for cancer imaging and therapy. My work focuses on the design, synthesis, bioconjugation, and radiolabeling of biomolecules such as peptides and monoclonal antibodies targeting cancer-related biomarkers, including PD-L1. I am also interested in bioorthogonal chemistry, molecular imaging, and translational approaches in nuclear medicine and oncology.